Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks

Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks

BackgroundThe aim of this multicenter, randomized, double-blind study was to examine the effect of lobeglitazone, a novel thiazolidinedione, on the changes in bone mineral density (BMD) in patients with type 2 diabetes mellitus.MethodsA 24-week, double-blinded phase was followed by a 28-week, open-l...

Full description

Bibliographic Details
Main Authors: Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
Format: Article
Language:English
Published: Korean Diabetes Association 2017-10-01
Series:Diabetes & Metabolism Journal
Subjects:
Bone density
Diabetes mellitus, type 2
Lobeglitazone
Thiazolidinediones
Online Access:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-377.pdf

Internet

https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-377.pdf

Similar Items